医药精细化学品市场：按类型、按产品、按应用、按地区

受 2024 年至 2031 年 8% 复合年增长率的推动，医药精细化学品市场预计将呈现显着增长，从 2024 年的 1,362 亿美元增至 2031 年的 2,335 亿美元。

图1. 2024年医药精细化学品市场区域份额（%）

近年来，医药精细化学品市场经历了显着成长。医药精细化学品是指用于药物製剂的活性药物成分及原料药。慢性病增加、老年人口增加以及生物製药公司对药物开发的研发投入增加等因素正在推动对医药精细化学品的需求。此外，自订合成和製造服务越来越受欢迎，因为它们可以帮助药厂优化成本并专注于其他活动。原料药製造商和製剂公司之间的各种长期供应协议也支撑着医药精细化学品市场。然而，严格的法律规范和与药物开发过程相关的高成本给推动市场成长带来了挑战。总体而言，全球医药精细化学品市场预计在未来几年将呈现利润丰厚的机会。

市场动态：

医药精细化学品市场是由世界老年人口增加（更容易患慢性病）、医疗保健支出增加以及文明病患病率增加等因素所推动的。据联合国称，到2050年，世界上六分之一的人将超过65岁。此外，製药公司用于药物开发和采用契约製造支出的增加正在推动市场成长。然而，他们面临药品核准严格的法规环境以及药品製造相关的高成本等挑战。同时，在原料药生产过程中越来越多地采用自订合成和製造，为相关人员提供了巨大的机会。此外，将原料药製造外包到低成本和熟练劳动力的新兴市场正在为市场相关人员开闢新的途径。

本研究的主要特点

• 本报告对全球医药精细化学品市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
• 它还强调了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球医药精细化学品市场的主要企业。
• 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
• 全球医药精细化学品市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

目录：

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场概况

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
• 对生物相似药的需求不断增长
• 政府医疗保健支出增加
  • 抑制因素
• 由于合规性导致生产成本增加
• 容量限制 输出限制
  • 机会
• 精细化工製造外包
• 生技药品和生物相似药市场的成长
• 影响分析
• 主要亮点
• 监管场景
• 产品发布/核准
• PEST分析
• 波特的分析
• 併购场景

第四章医药精细化学品市场-冠状病毒（COVID-19）大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第五章 2019-2031 年医药精细化学品市场（按类型）

• 独家的
• 非排他性

第六章 医药精细化学品市场，分产品，2019-2031

• 基本构建块
• 进阶中级
• 有效成分

第七章 2019-2031 年医药精细化学品市场（依应用）

• 心血管
• 神经系统
• 肿瘤学
• 感染疾病
• 代谢系统
• 糖尿病
• 呼吸系统
• 胃
• 黏膜骨架
• 其他的

第八章 2019-2031年医药精细化学品市场（按地区）

• 北美洲
• 美国
• 加拿大
• 欧洲
• 英国
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 欧洲其他地区
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• ASEAN
• 其他亚太地区
• 中东/非洲
• GCC
• 以色列
• 其他中东地区
• 拉丁美洲
• 墨西哥
• 阿根廷
• 巴西

第9章 竞争格局

• 公司简介
  • Denisco
  • Albemarle Corporation
  • Kenko Corporation
  • GRACE
  • CHEMADA
  • JMP Statistical Discovery LLC.
  • Pfizer Inc.
  • GSK plc

第10章

• 调查方法
• 关于出版商

The pharmaceutical fine chemicals market is projected to exhibit substantial growth, increasing from US$ 136.2 Bn in 2024 to an estimated US$ 233.5 Bn by 2031 this growth is anticipated to be driven by a notable CAGR of 8% during the period of 2024-2031.

Figure 1. Pharmaceutical Fine Chemicals Market Share (%), by Region, 2024

The pharmaceutical fine chemicals market has been witnessing significant growth over the past few years. Pharmaceutical fine chemicals refer to active pharmaceutical ingredients or bulk drug substances which are used in pharmaceutical formulations. Factors, such as rising prevalence of chronic diseases, increasing elderly population, and growing research and development investments in drug development by biopharmaceutical companies, are fueling the demand for pharmaceutical fine chemicals. Furthermore, custom synthesis and manufacturing services are gaining traction as they help drug manufacturers optimize costs and focus on other core activities. Various agreements between Active Pharmaceutical Ingredients makers and drug formulation businesses for long term supply are also propelling the pharmaceutical fine chemicals market. However, stringent regulatory framework and high costs associated with drug development processes pose challenges to boost the market growth. Overall, the global pharmaceutical fine chemicals market is anticipated to showcase lucrative opportunities in the coming years.

Market Dynamics:

The pharmaceutical fine chemicals market is driven by factors such as growing geriatric population globally prone to chronic diseases, rising healthcare expenditure, and increasing incidence of lifestyle diseases. As per the United Nations, by 2050, one in six people in the world will be over age 65. Furthermore, increasing R&D spending on drug development by pharmaceutical companies and the adoption of contract manufacturing are fueling the market growth. However, the market faces challenges from stringent regulatory environment for drug approval and high costs associated with drug manufacturing. On the other hand, the growing adoption of custom synthesis and manufacturing in the API production process presents significant opportunities for stakeholders. Additionally, outsourcing of API manufacturing to emerging markets with low-cost skilled labor is opening new avenues for market players.

Key features of the study:

• This report provides an in-depth analysis of the global pharmaceutical fine chemicals market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pharmaceutical fine chemicals market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Denisco, Albemarle Corporation, Kenko Corporation, GRACE, CHEMADA, JMP Statistical Discovery LLC., Pfizer Inc., GSK plc.,
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global pharmaceutical fine chemicals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation:

• Pharmaceutical Fine Chemicals Market, By Type
  • Proprietary
  • Non Proprietary
• Pharmaceutical Fine Chemicals Market, By Product
  • Basic Building Blocks
  • Advanced Intermediates
  • Active Ingredients
• Pharmaceutical Fine Chemicals Market, By Application
  • Cardiovascular
  • Neurological
  • Oncological
  • Infectious Diseases
  • Metabolic System
  • Diabetes
  • Respiratory
  • Gastrointestinal
  • Mucoskeletal
  • Others
• Pharmaceutical Fine Chemicals Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
• Top companies in the pharmaceutical fine chemicals market
  • Denisco
  • Albemarle Corporation
  • Kenko Corporation
  • GRACE
  • CHEMADA
  • JMP Statistical Discovery LLC.
  • Pfizer Inc.
  • GSK plc.

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Product
  • Market Snippet, By Application
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Rising Demand for Biosimilars
• Increasing Government Healthcare Spending
  • Restraints
• Regulatory Compliance Increasing Production Costs
• Capacity Limitations Restricting Output
  • Opportunities
• Outsourcing of Fine Chemicals Production
• Growth in Biologics and Biosimilars Market
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Pharmaceutical Fine Chemicals Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Pharmaceutical Fine Chemicals Market, By Type, 2019 - 2031 (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Proprietary
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
• Non Proprietary
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)

6. Pharmaceutical Fine Chemicals Market, By Product, 2019 - 2031 (US$ Bn)

• Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Basic Building Blocks
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
• Advanced Intermediates
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
• Active Ingredients
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)

7. Pharmaceutical Fine Chemicals Market, By Application, 2019 - 2031 (US$ Bn)

• Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
• Neurological
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
• Oncological
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
• Metabolic System
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
• Respiratory
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
• Gastrointestinal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
• Mucoskeletal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)

8. Pharmaceutical Fine Chemicals Market, By Region, 2019 - 2031 (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020 - 2031
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031,(US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031,(US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest Of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031,(US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• Asean
• Rest Of Asia Pacific
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031,(US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031,(US$ Bn)
• Mexico
• Argentina
• Brazil

9. Competitive Landscape

• Company Profiles
  • Denisco
• Company Highlights
• Product/Service Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Albemarle Corporation
• Company Highlights
• Product/Service Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Kenko Corporation
• Company Highlights
• Product/Service Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • GRACE
• Company Highlights
• Product/Service Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • CHEMADA
• Company Highlights
• Product/Service Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • JMP Statistical Discovery LLC.
• Company Highlights
• Product/Service Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Pfizer Inc.
• Company Highlights
• Product/Service Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • GSK plc
• Company Highlights
• Product/Service Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Analyst Views

10. Section

• Research Methodology
• About us